Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Minocycline superior to placebo for early RA

June 25, 1997

Merck Frosst prepares prodrugs of COX-2 inhibitors

June 23, 1997

Hoechst prepares compounds for degenerative and inflammatory disorders

June 18, 1997

New antiarthritic agent from Czech research institute characterized

June 16, 1997

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

Clinical safety and efficacy of TS-110 for inflammation and pain

June 12, 1997

Long-term Enbrel safe and effective in RA

June 11, 1997

Development of anti-cytokine antibody product for RA progresses

June 9, 1997

Astra discloses iNOS inhibitors

June 9, 1997

COX-2 inhibitors from Merck Frosst

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...